Enabling technology for therapeutics targeting membrane proteins

G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation.

We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform.

G.Mixes®
G.Select® Assay
G.Lipidomics®
G.Validation® Assay

We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRs, Receptors, Transmembrane Proteins) that would like to ascertain the necessary environment and conformation stabilization for their targets at all steps of development.

– Delivery of membrane proteins purified and stabilized in the desired conformation and specific environment for screening

– Delivery of membrane proteins purified and stabilized in the desired conformation and specific environment for immunization

– Mechanism of action and functional testing of drugs and antibody candidates on membrane protein stabilized in specific conformation(s) and environment(s)

– Target validation and profiling of drugs and antibody hits, leads and clinical candidates